United States

Arrowhead Pharmaceuticals Inc (ARWR.OQ)

ARWR.OQ on NASDAQ Stock Exchange Global Select Market

26 Apr 2017
Change (% chg)

$0.01 (+0.66%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Arrowhead reports qtrly loss per share $0.17
Monday, 6 Feb 2017 04:00pm EST 

Arrowhead Pharmaceuticals Inc : Arrowhead reports fiscal 2017 first quarter results .Qtrly loss per share (basic and diluted) $0.17.  Full Article

Silence Therapeutics Plc reports 9.21 percent stake in Arrowhead Pharmaceuticals Inc as of Jan 3 - SEC filing
Friday, 13 Jan 2017 09:01am EST 

Arrowhead Pharmaceuticals Inc : Silence Therapeutics Plc reports 9.21 percent stake in Arrowhead Pharmaceuticals Inc as of Jan 3 - SEC filing . Silence Therapeutics says acquired Arrowhead Pharmaceuticals' common stock in order to facilitate discussions regarding possible transaction .Silence Therapeutics says transaction could include, but not limited to, product licensing, research and development collaboration, technology sharing or potential corporate transaction.  Full Article

Silence Therapeutics buys stake in Arrowhead Pharmaceuticals
Monday, 9 Jan 2017 02:00am EST 

Silence Therapeutics Plc : Acquired stake in arrowhead pharmaceuticals, inc of 6,006,359 common shares, representing 8.4 pct of common share capital .Deal for cash consideration of $9.6 million (7.8 million stg), excluding transaction costs..  Full Article

Arrowhead Pharma notified company's Chief Scientific Officer, that his position will be terminated
Thursday, 1 Dec 2016 05:43pm EST 

Arrowhead Pharmaceuticals Inc :Arrowhead Pharmaceuticals - Notified David Lewis, company's chief scientific officer, that his position will be terminated, effective December 13.  Full Article

Arrowhead Pharmaceuticals announces sale of about 7.6 mln shares
Friday, 2 Sep 2016 04:10pm EDT 

Arrowhead Pharmaceuticals Inc :Sale of an aggregate of 7.6 million shares of common stock, $0.001 par value per share by selling stockholders - sec filing.  Full Article

Arrowhead Pharma qtrly loss $0.32 per share
Tuesday, 9 Aug 2016 04:01pm EDT 

: Arrowhead reports fiscal 2016 third quarter results .Arrowhead pharmaceuticals inc qtrly basic and diluted loss per share $0.32.  Full Article

Arrowhead Pharmaceuticals reports Q2 loss per share $0.35
Tuesday, 10 May 2016 04:01pm EDT 

Arrowhead Pharmaceuticals Inc : Q2 loss per share $0.35 .Q2 earnings per share view $-0.37 -- Thomson Reuters I/B/E/S.  Full Article

Arrowhead Research Corp changes name to Arrowhead Pharmaceuticals
Wednesday, 6 Apr 2016 04:01pm EDT 

Arrowhead Research Corp:Has changed its corporate name to Arrowhead Pharmaceuticals Inc.  Full Article

Arrowhead Research Corp's ARC-AAT Granted EMA Orphan Drug Designation
Tuesday, 19 Jan 2016 07:30am EST 

Arrowhead Research Corp:Says arrowhead's arc-aat granted ema orphan drug designation.  Full Article

Arrowhead Research Corp receives regulatory clearance to begin additional phase 2b studies of hepatitis B candidate ARC-520
Wednesday, 17 Jun 2015 07:30am EDT 

Arrowhead Research Corp:Says its clinical trial application for ARC-520, its clinical candidate for chronic hepatitis B infection (HBV), has been approved by Germany's Federal Institute for Drugs and Medical Devices.The company now has regulatory clearance in Germany for two additional Phase 2b multiple dose studies of ARC-520 to be conducted in parallel.  Full Article

More From Around the Web